HB
CODX

Horizon Bancorp’s Co-Diagnostics CODX Stock Holding History

Horizon Bancorp’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$15K Hold
37
– – 0.02% 193
2020
Q2 		$22K Hold
37
– – 0.02% 183
2020
Q1 		$9K Buy
+37
New +$6.42K 0.01% 224

Other funds holding CODX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
IA
IFG Advisory Atlanta, Georgia $34.9M AUM 20.48% 1-Year Est. Return

Horizon Bancorp's CODX Position: Q3 2020 in Review

Horizon Bancorp held its Co-Diagnostics (CODX) position steady in Q3 2020 at 37 shares worth $15K. The position accounts for 0.02% of the portfolio, ranked #193.

Horizon Bancorp first reported a position in CODX in Q1 2020 and has held it in 3 quarters since. The position peaked at $22K in Q2 2020. 81 funds tracked by Wall St. Rank hold CODX as of Q3 2020.

  • Horizon Bancorp held 37 shares of Co-Diagnostics worth $15K as of Q3 2020.
  • Horizon Bancorp left its Co-Diagnostics share count unchanged in Q3 2020.
  • Co-Diagnostics made up 0.02% of Horizon Bancorp's portfolio in Q3 2020, its #193 holding.
  • Horizon Bancorp first reported a position in Co-Diagnostics in Q1 2020 and has held it in 3 quarters since.
  • Horizon Bancorp's Co-Diagnostics position peaked at $22K in Q2 2020.
  • 81 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2020.

Based on Horizon Bancorp's 13F filing for Q3 2020, filed 12 Nov 2020.